Denny Ausiello

Track

Insider profile

Currently holds positions in Alnylam Pharmaceuticals Inc and Seres Therapeutics Inc

Positions

Position Company Period
Independent Director Alnylam Pharmaceuticals Inc April 20, 2012 -
Independent Director Seres Therapeutics Inc April 1, 2015 -
Lead Independent Director Pfizer Inc April 1, 2015 - Jan. 1, 2018
Independent Director Pfizer Inc Dec. 1, 2006 - April 1, 2015
Denny Ausiello's trades of Alnylam Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
433.59
Quantity 31,448
Value US$13,635,538
Transaction date
Proposed sale
Price
266.66
Quantity 20,250
Value US$5,399,865
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-08-15 2025-08-14
PlS Planned sale
9,543 +1.1%
117.41
US$3,361,517 		9,543 +1.1% 117.41 US$3,361,517
2025-08-15 2025-08-14
PlS Planned sale
39,140 -26.4%
484.99
US$2,816,293 		39,140 -26.4% 484.99 US$2,816,293
2025-08-15 2025-08-14
PlS Planned sale
68,617 +2.4%
469.65
US$578,131 		68,617 +2.4% 469.65 US$578,131
2025-08-15 2025-08-14
PlS Planned sale
5,302 -57.0%
439.27
US$2,329,010 		5,302 -57.0% 439.27 US$2,329,010
2025-08-15 2025-08-14
PlS Planned sale
2,086 -18.3%
438.34
US$914,377 		2,086 -18.3% 438.34 US$914,377
2025-08-15 2025-08-14
PlS Planned sale
1,922 -14.4%
437.56
US$840,990 		1,922 -14.4% 437.56 US$840,990
2025-08-15 2025-08-14
PlS Planned sale
5,358 -28.7%
436.00
US$2,336,088 		5,358 -28.7% 436.00 US$2,336,088
2025-08-15 2025-08-14
PlS Planned sale
7,675 -29.1%
435.40
US$3,341,695 		7,675 -29.1% 435.40 US$3,341,695
2025-08-15 2025-08-14
PlS Planned sale
2,098 -7.4%
434.50
US$911,581 		2,098 -7.4% 434.50 US$911,581
2025-08-15 2025-08-14
PlS Planned sale
1,938 -6.4%
432.94
US$839,038 		1,938 -6.4% 432.94 US$839,038
2025-08-15 2025-08-14
PlS Planned sale
1,985 -6.1%
430.81
US$855,158 		1,985 -6.1% 430.81 US$855,158
2025-08-14 2025-08-14
PrS Proposed sale
31,448
433.59
US$13,635,538 		31,448 433.59 US$13,635,538
2024-08-08 2024-08-06
PlS Planned sale
262 -65.8%
266.45
US$69,810 		262 -65.8% 266.45 US$69,810
2024-08-08 2024-08-06
PlS Planned sale
632 -61.4%
264.95
US$167,448 		632 -61.4% 264.95 US$167,448
2024-08-08 2024-08-06
PlS Planned sale
3,408 -76.8%
263.72
US$898,758 		3,408 -76.8% 263.72 US$898,758
2024-08-08 2024-08-06
PlS Planned sale
4,367 -49.6%
262.79
US$1,147,604 		4,367 -49.6% 262.79 US$1,147,604
2024-08-08 2024-08-06
PlS Planned sale
6,212 -41.4%
261.63
US$1,625,246 		6,212 -41.4% 261.63 US$1,625,246
2024-08-08 2024-08-06
PlS Planned sale
3,742 -19.9%
260.40
US$974,417 		3,742 -19.9% 260.40 US$974,417
2024-08-08 2024-08-06
PlS Planned sale
1,627 -8.0%
259.56
US$422,304 		1,627 -8.0% 259.56 US$422,304
2024-08-06 2024-08-06
PrS Proposed sale
20,250
266.66
US$5,399,865 		20,250 266.66 US$5,399,865
2022-11-23 2022-11-21
PlS Planned sale
22,500 -100.0%
220.00
US$4,950,000 		22,500 -100.0% 220.00 US$4,950,000